Esmee H Runhart1,2, Dyon Valkenburg1,2, Stéphanie S Cornelis2,3, Mubeen Khan2,3, Riccardo Sangermano3,4, Silvia Albert2,3, Nathalie M Bax1,2, Galuh D N Astuti3,5, Christian Gilissen2,3, Jan-Willem R Pott6, Joke B G M Verheij7, Ellen A W Blokland3, Frans P M Cremers2,3, L Ingeborgh van den Born8, Carel B Hoyng1,2. 1. Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands. 2. Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands. 3. Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands. 4. Ocular Genomics Institute, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States. 5. Division of Human Genetics, Center for Biomedical Research, Faculty of Medicine, Diponegoro University, Semarang, Indonesia. 6. Department of Ophthalmology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. 7. Department of Medical Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. 8. The Rotterdam Eye Hospital, Rotterdam, The Netherlands.
Abstract
Purpose: To investigate the role of two deep-intronic ABCA4 variants, that showed a mild splice defect in vitro and can occur on the same allele as the low penetrant c.5603A>T, in Stargardt disease (STGD1). Methods: Ophthalmic data were assessed of 18 STGD1 patients who harbored c.769-784C>T or c.4253+43G>A in combination with a severe ABCA4 variant. Subjects carrying c.[769-784C>T; 5603A>T] were clinically compared with a STGD1 cohort previously published carrying c.5603A>T noncomplex. We calculated the penetrances of the intronic variants using ABCA4 allele frequency data of the general population and investigated the effect of c.769-784C>T on splicing in photoreceptor progenitor cells (PPCs). Results: Mostly, late-onset, foveal-sparing STGD1 was observed among subjects harboring c.769-784C>T or c.4253+43G>A (median age of onset, 54.5 and 52.0 years, respectively). However, ages of onset, phenotypes in fundo, and visual acuity courses varied widely. No significant clinical differences were observed between the c.[769-784C>T; 5603A>T] cohort and the c.4253+43G>A or the c.5603A>T cohort. The penetrances of c.769-784C>T (20.5%-39.6%) and c.4253+43G>A (35.8%-43.1%) were reduced, when not considering the effect of yet unidentified or known factors in cis, such as c.5603A>T (identified in 7/7 probands with c.769-784C>T; 1/8 probands with c.4253+43G>A). Variant c.769-784C>T resulted in a pseudo-exon insertion in 15% of the total mRNA (i.e., ∼30% of the c.769-784C>T allele alone). Conclusions: Two mild intronic ABCA4 variants could further explain missing heritability in late-onset STGD1, distinguishing it from AMD. The observed clinical variability and calculated reduced penetrance urge research into modifiers within and outside of the ABCA4 gene.
Purpose: To investigate the role of two deep-intronic ABCA4 variants, that showed a mild splice defect in vitro and can occur on the same allele as the low penetrant c.5603A>T, in Stargardt disease (STGD1). Methods: Ophthalmic data were assessed of 18 STGD1patients who harbored c.769-784C>T or c.4253+43G>A in combination with a severe ABCA4 variant. Subjects carrying c.[769-784C>T; 5603A>T] were clinically compared with a STGD1 cohort previously published carrying c.5603A>T noncomplex. We calculated the penetrances of the intronic variants using ABCA4 allele frequency data of the general population and investigated the effect of c.769-784C>T on splicing in photoreceptor progenitor cells (PPCs). Results: Mostly, late-onset, foveal-sparing STGD1 was observed among subjects harboring c.769-784C>T or c.4253+43G>A (median age of onset, 54.5 and 52.0 years, respectively). However, ages of onset, phenotypes in fundo, and visual acuity courses varied widely. No significant clinical differences were observed between the c.[769-784C>T; 5603A>T] cohort and the c.4253+43G>A or the c.5603A>T cohort. The penetrances of c.769-784C>T (20.5%-39.6%) and c.4253+43G>A (35.8%-43.1%) were reduced, when not considering the effect of yet unidentified or known factors in cis, such as c.5603A>T (identified in 7/7 probands with c.769-784C>T; 1/8 probands with c.4253+43G>A). Variant c.769-784C>T resulted in a pseudo-exon insertion in 15% of the total mRNA (i.e., ∼30% of the c.769-784C>T allele alone). Conclusions: Two mild intronic ABCA4 variants could further explain missing heritability in late-onset STGD1, distinguishing it from AMD. The observed clinical variability and calculated reduced penetrance urge research into modifiers within and outside of the ABCA4 gene.
Authors: Esmee H Runhart; Patty Dhooge; Magda Meester-Smoor; Jeroen Pas; Jan Willem R Pott; Redmer van Leeuwen; Hester Y Kroes; Arthur A Bergen; Yvonne de Jong-Hesse; Alberta A Thiadens; Mary J van Schooneveld; Maria van Genderen; Camiel Boon; Caroline Klaver; L Ingeborg van den Born; Frans P M Cremers; Carel B Hoyng Journal: Acta Ophthalmol Date: 2021-08-25 Impact factor: 3.988
Authors: Stéphanie S Cornelis; Esmee H Runhart; Miriam Bauwens; Zelia Corradi; Elfride De Baere; Susanne Roosing; Lonneke Haer-Wigman; Claire-Marie Dhaenens; Anneke T Vulto-van Silfhout; Frans P M Cremers Journal: Am J Hum Genet Date: 2022-02-03 Impact factor: 11.043
Authors: Esmee H Runhart; Mubeen Khan; Stéphanie S Cornelis; Susanne Roosing; Marta Del Pozo-Valero; Tina M Lamey; Petra Liskova; Lisa Roberts; Heidi Stöhr; Caroline C W Klaver; Carel B Hoyng; Frans P M Cremers; Claire-Marie Dhaenens Journal: JAMA Ophthalmol Date: 2020-10-01 Impact factor: 7.389
Authors: Tomasz Z Tomkiewicz; Nuria Suárez-Herrera; Frans P M Cremers; Rob W J Collin; Alejandro Garanto Journal: Int J Mol Sci Date: 2021-04-28 Impact factor: 5.923
Authors: Winston Lee; Jana Zernant; Takayuki Nagasaki; Laurie L Molday; Pei-Yin Su; Gerald A Fishman; Stephen H Tsang; Robert S Molday; Rando Allikmets Journal: Hum Mol Genet Date: 2021-06-26 Impact factor: 5.121
Authors: Mubeen Khan; Gavin Arno; Ana Fakin; David A Parfitt; Patty P A Dhooge; Silvia Albert; Nathalie M Bax; Lonneke Duijkers; Michael Niblock; Kwan L Hau; Edward Bloch; Elena R Schiff; Davide Piccolo; Michael C Hogden; Carel B Hoyng; Andrew R Webster; Frans P M Cremers; Michael E Cheetham; Alejandro Garanto; Rob W J Collin Journal: Mol Ther Nucleic Acids Date: 2020-06-12 Impact factor: 8.886
Authors: Rachael C Heath Jeffery; Syed Aqif Mukhtar; Ian L McAllister; William H Morgan; David A Mackey; Fred K Chen Journal: Ophthalmic Genet Date: 2021-05-03 Impact factor: 1.803